Targeted radiation therapy for high-risk prostate cancer
PSMA/MR-guided Stereotactic Body Radiotherapy for High Risk Prostate Cancer
This study is exploring a new way to treat high-risk prostate cancer by using special imaging techniques to find cancer spots more accurately, so patients can receive targeted radiation therapy in just five sessions, which aims to reduce side effects and improve treatment results.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10440533 on NIH RePORTER |
What this research studies
This research investigates a new approach to treating high-risk prostate cancer using advanced imaging and radiation techniques. It combines PSMA PET and MRI to accurately identify cancerous areas within the prostate, allowing for a more precise delivery of radiation therapy. The treatment is designed to be completed in just five sessions, minimizing toxicity while aiming to improve outcomes for patients with aggressive cancer. By utilizing real-time adaptive planning during radiation delivery, the therapy can be tailored to the patient's specific needs.
Who could benefit from this research
Good fit: Ideal candidates for this research are men diagnosed with high-risk localized prostate cancer who are seeking advanced treatment options.
Not a fit: Patients with low-risk prostate cancer or those who have already undergone extensive treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve survival rates and reduce recurrence in patients with high-risk prostate cancer.
How similar studies have performed: Other research has shown promising results using similar imaging and radiation techniques, indicating potential for success in this novel approach.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Formenti, Silvia C. — Weill Medical Coll of Cornell Univ
- Study coordinator: Formenti, Silvia C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.